A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Mizkif mocks Adin Ross for his 'pretty crazy' Kick ban comments: 'I have a Rumble deal'
Biden’s Ethanol Plan Rattles an Industry Already Under Pressure
Jim Jordan scraps committee contempt vote on Mark Zuckerberg
Is Warzone Shutting Down in 2023?
Tristan Tate exposes dating app doppelgangers, unveils mystery behind his face as go-to profile pic: 'I’m a super popular catfish avatar'
Screen sharing might be coming to WhatsApp for Android
Modern Warfare 3 Developers Tease Slide Cancel Return in Unexpected Way
China spy agency's social media debut calls for 'all members of society' to combat espionage